Virtu Financial LLC decreased its position in shares of ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) by 82.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 11,693 shares of the company’s stock after selling 54,214 shares during the quarter. Virtu Financial LLC’s holdings in ASP Isotopes were worth $33,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp purchased a new stake in ASP Isotopes during the second quarter valued at about $381,000. Fielder Capital Group LLC bought a new stake in shares of ASP Isotopes in the second quarter valued at approximately $55,000. Rhumbline Advisers purchased a new stake in shares of ASP Isotopes during the 2nd quarter valued at approximately $116,000. Rathbones Group PLC boosted its holdings in ASP Isotopes by 27.5% in the 2nd quarter. Rathbones Group PLC now owns 195,915 shares of the company’s stock worth $600,000 after buying an additional 42,243 shares during the period. Finally, Renaissance Technologies LLC grew its stake in ASP Isotopes by 5.7% in the 2nd quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock valued at $526,000 after buying an additional 9,200 shares in the last quarter. Institutional investors own 16.80% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on the company. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th. Canaccord Genuity Group initiated coverage on ASP Isotopes in a report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective on the stock.
ASP Isotopes Stock Performance
ASP Isotopes stock opened at $4.89 on Friday. The firm’s 50 day simple moving average is $5.83 and its 200 day simple moving average is $3.91. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a 1-year low of $1.65 and a 1-year high of $9.33. The firm has a market capitalization of $349.10 million, a PE ratio of -8.02 and a beta of 3.27.
About ASP Isotopes
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
See Also
- Five stocks we like better than ASP Isotopes
- Stock Average Calculator
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Investing in Travel Stocks Benefits
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What does consumer price index measure?
- 2 Underrated Quantum Computing Companies Starting to Rally
Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPI – Free Report).
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.